Literature DB >> 16963041

Plasma adrenomedullin levels in patients with polycystic ovary syndrome.

Banu Ucar1, Volkan Noyan, Osman Caglayan, Aykan Yucel, Nevin Sagsoz.   

Abstract

OBJECTIVE: To evaluate adrenomedullin levels in patients with polycystic ovary syndrome (PCOS).
DESIGN: Prospective study.
SETTING: Department of obstetrics and gynecology in a university hospital. PATIENT(S): Thirty-eight women with PCOS and 29 healthy control subjects were enrolled in the study. INTERVENTION(S): Plasma adrenomedullin, serum androstenedione, free T, T, DHEAS, SHBG, thyrotropin, PRL, FSH, LH, and E2 were measured in each subject. Insulin resistance was estimated by fasting insulin level, fasting glucose:insulin ratio and 75-g glucose tolerance test for 2 hours. MAIN OUTCOME MEASURE(S): Plasma adrenomedullin levels and correlations among adrenomedullin and gonadotropins, female sex steroids, androgens, and insulin resistance. RESULT(S): There was no significant difference concerning plasma adrenomedullin concentrations between the groups. In patients with PCOS, fasting glucose, fasting insulin, body mass index, and free T were inversely correlated with the plasma adrenomedullin. Plasma adrenomedullin was significantly correlated with glucose:insulin ratio. After controlling for body mass index, there were no significant correlations between the above-mentioned parameters. CONCLUSION(S): Adrenomedullin may play a role in regulating the insulin metabolism in patients with PCOS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16963041     DOI: 10.1016/j.fertnstert.2006.02.119

Source DB:  PubMed          Journal:  Fertil Steril        ISSN: 0015-0282            Impact factor:   7.329


  2 in total

1.  Adrenomedullin: possible predictor of insulin resistance in women with polycystic ovary syndrome.

Authors:  I Sahin; O Celik; N Celik; L Keskin; A Dogru; I Dogru; M Yürekli; S Yologlu
Journal:  J Endocrinol Invest       Date:  2011-07-25       Impact factor: 4.256

2.  Effect of liraglutide on atrial natriuretic peptide, adrenomedullin, and copeptin in PCOS.

Authors:  Signe Frøssing; Malin Nylander; Caroline Kistorp; Sven O Skouby; Jens Faber
Journal:  Endocr Connect       Date:  2018-01       Impact factor: 3.335

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.